Minerva Stock Drops On Initial Reaction To Data, But Multiple Catalysts Are On The Way - Seeking Alpha

Submitted by Anonymous (not verified) on Tue, 05/14/2019 - 22:44

Minerva Stock Drops On Initial Reaction To Data, But Multiple Catalysts Are On The Way  Seeking AlphaMinerva Neurosciences released results from its phase 2b study using Seltorexant to treat patients with major depressive disorder. The initial reaction to the p.